A popular article has been spreading across Facebook, claiming that the simple anthelmintic drug fenbendazole for humans can cure cancer. This article claims that fenbendazole, which is used to treat parasitic infections in animals, works by blocking the signalling pathways that fuel cancer cell growth.
It also supposedly acts as an anti-inflammatory, helping the body cope with chemotherapy and radiation side effects. The article says that fenbendazole can be found at pharmacies and is inexpensive to produce. The author of the article also claims that it can be used in conjunction with other treatments like ozone therapy and hyperbaric oxygen chambers to achieve even better results.
Research into new anticancer drugs takes a lot of time and money. Developing drugs from promising molecules through to a finished product often requires several years. Repurposing existing veterinary drugs that already have a good safety margin for human use saves time and money, and may provide quicker access to effective therapies.
The article mentions studies showing that fenbendazole slows down cancer cell growth in both animal and cell cultures. It also states that a number of studies have shown that fenbendazole can help reduce tumor size in mice when combined with other conventional cancer treatments.
While these studies are interesting, there isn’t enough evidence from randomized clinical trials to prove that fenbendazole is effective in humans. These trials need to include a large number of patients with different types of cancers and measure the effectiveness of the drug in combination with other cancer treatments.
In addition to the research showing that fenbendazole inhibits cancer cell growth, there are also studies suggesting that it can help prevent resistance to other cancer treatments. This is because fenbendazole works by targeting multiple pathways in the cell that are involved in tumorigenesis. This is important because it means that the drug is more likely to evade the common form of resistance that develops when single-target drugs are used alone.
A study published in Scientific Reports also investigated whether fenbendazole would have any impact on the radiosensitivity of human EMT6 tumors. The authors found that three daily i.p. injections of fenbendazole had no effect on the growth of unirradiated tumors, but significantly reduced the rate at which they metastasized to distant organs after receiving 10 Gy of x-ray treatment.
While fenbendazole is an established drug that has been approved to treat parasitic infections in people, it’s not currently licensed as a cancer treatment. It’s possible that this will change in the future, but at present there isn’t sufficient evidence that fenbendazole is an effective cancer treatment. While it is an interesting discovery, there are a number of other factors that could explain the anecdotal story of Joe Tippens’ remission, such as the conventional cancer treatments he received that may have been more influential than fenbendazole. This is why Health Feedback is unable to recommend this protocol to readers. fenbendazole for humans